UpRight Science Acquires FDA-Cleared Balance Assessment Technology

UpRight Science has completed the acquisition of Highmark's balance assessment application, a move aimed at enhancing clinical care for older adults. The deal, announced on June 16, 2026, involves an undisclosed amount and positions UpRight Science to integrate clinically validated balance measurement technology into routine healthcare practices. This acquisition is significant as it addresses a critical gap in the assessment of balance, which is a key indicator of overall health, particularly among the aging population.

Highmark's balance assessment application utilizes FDA-cleared technology to provide healthcare providers with an objective and precise method for measuring balance. This capability allows clinicians to track balance over time and identify potential issues before they result in falls, a major concern for older adults, with one in four experiencing a fall each year. The technology developed by Highmark has been clinically validated within its ecosystem, ensuring that it meets rigorous standards for accuracy and reliability in a clinical setting.

The strategic rationale behind this acquisition is multifaceted. UpRight Science aims to elevate the standard of care for balance assessment, which has historically been overlooked in routine clinical evaluations. By integrating Highmark's technology, UpRight Science enhances its existing portfolio of FDA-cleared balance assessment tools and aligns with its mission to provide comprehensive care solutions that address the needs of older adults. Dr. Sanjeev Sharma, Chief Medical Officer at UpRight Science, emphasized the importance of tracking balance as a vital sign, akin to monitoring temperature or blood pressure, which can lead to proactive interventions and improved patient outcomes.

The medical technology sector is increasingly recognizing the importance of data-driven solutions in preventive care. With an aging population that is at heightened risk for falls, the demand for effective balance assessment tools is expected to grow. UpRight Science's acquisition of Highmark's technology not only strengthens its position in the market but also reflects a broader trend toward integrating innovative solutions that enhance patient care and safety.

As UpRight Science moves forward with the integration and development of Highmark's balance assessment application, the implications for the healthcare industry could be substantial. The ability to routinely assess and monitor balance may lead to a paradigm shift in how clinicians approach preventive care for older adults. This acquisition positions UpRight Science as a leader in the medical technology space, potentially setting new standards for balance assessment and ultimately contributing to improved health outcomes for a vulnerable population.